No Data
Pasithea Therapeutics Announces SRC Recommended Proceeding to Cohort 4
Express News | Pasithea Therapeutics Corp - Src Recommends Escalation to 15Mg Dose Level
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation From Its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Express News | Pasithea Therapeutics Announces Positive Safety Review Committee (Src) Recommendation From Its Ongoing Phase 1 Clinical Trial of Pas-004 in Advanced Cancer
10-Q: Q3 2024 Earnings Report
Pasithea Therapeutics Files to Sell 3.74M Shares of Common Stock for Holders
No Data
No Data
with the color comment... hey, you can add target to the list too
that mustache 
